fda_approval · anda · info

AUROBINDO PHARMA — ANDA approval: CEPHALEXIN (unspecified)

Event date
2026-06-09 00:00:00Z
Observed
2026-07-09 22:53:29Z
Source ID
ANDA213568-1
Payload hash
f45b6db29564389e8918b0b9

Summary

AUROBINDO PHARMA received ANDA approval for CEPHALEXIN (unspecified) on 2026-06-09. Dosage form: FOR SUSPENSION. Application #: ANDA213568.

Informational only. Not legal, financial, or medical advice.